Undervalued Biotech Stocks Shine: Pfizer and BioNTech Show Robust Resilience
GuruFocus.com via Yahoo Finance· 3 hours agoIn the ever-evolving world of the stock market, uncovering potential gold mines is paramount for...
Biotech Stock Roundup: ICPT Up on Buyout Deal, IMVT & PLRX Gain on Study Data
Zacks via Yahoo Finance· 4 hours agoPerformance The Nasdaq Biotechnology Index has lost 0.59% in the past five trading sessions. Among...
Fortress Biotech, Inc. (NASDAQ:FBIO) CEO Lindsay A. Md Rosenwald Purchases 100,000 Shares of Stock
ETF DAILY NEWS· 11 hours agoFortress Biotech, Inc. (NASDAQ:FBIO – Get Free Report) CEO Lindsay A. Md Rosenwald acquired 100,000 shares of the stock in a transaction that occurred on Tuesday, September ...
7 'Strong Buy' Biotech Stocks to Rejuvenate Your Portfolio
InvestorPlace· 17 hours agoWhile the health innovation space presents wild risks, you could potentially swing the odds in your...
MIT grads launch climate biotech nonprofit and grant program
The Business Journals· 4 hours agoIn 2019, MIT Ph.D. students Daniel Goodwin and Paul Reginato began working on a way to build...
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Zacks via Yahoo Finance· 1 day ago(XBI) tracks S&P Biotechnology Select Industry Index and the iShares Biotechnology ETF (IBB) tracks...
What Is a Biotech ETF? Investing in Innovative Healthcare Technology
ETF.com· 2 days agoBiotech ETFs offer investors a convenient way to gain exposure to the dynamic and innovative biotechnology sector without the need to individually select ...
Biotech Got Whopped. But I've Got a Plan
TheStreet.com· 4 days agoThe surge in interest rates has helped trigger sharp selloff over the past week in biotech. Sure, Cisco Systems bought Splunk for $28 billion earlier...
Qihan Biotech announces the completion of pre-Series B financing for developing stem cell-derived...
Morningstar· 6 days agoHangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to ...
Morningstar's bullish on biotech; Pfizer's among the picks
TheStreet.com· 3 days agoRoche Morningstar fair value estimate: $56. Monday price quote: $34.15. "As the market leader in ...
Yahoo Web Search
Trending Now
